Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ

Clinical trial NCT06985602 · RECRUITING

Trial details

NCT number: NCT06985602
Sponsor: Jiangsu Cancer Institute & Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastroesophageal Adenocarcinoma Gastric Adenocarcinoma

Start date: 2025-05-16
Primary completion: 2027-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.